Multiple Myeloma

被引：58

作者：

Anderson, Kenneth C.

Alsina, Melissa ^{[1
]}

Bensinger, William

Biermann, J. Sybil ^{[2
]}

Chanan-Khan, Asher ^{[3
]}

Cohen, Adam D. ^{[4
]}

Devine, Steven ^{[5
,6
]}

Djulbegovic, Benjamin ^{[1
]}

Faber, Edward A., Jr. ^{[7
]}

Gasparetto, Cristina ^{[8
]}

Huff, Carol Ann ^{[9
]}

Kassim, Adetola ^{[10
]}

Medeiros, Bruno C. ^{[11
]}

Meredith, Ruby ^{[12
]}

Raje, Noopur ^{[13
]}

Schriber, Jeffrey ^{[14
]}

Singhal, Seema ^{[15
]}

Somlo, George

Stockerl-Goldstein, Keith ^{[16
,17
]}

Treon, Steven P.

Tricot, Guido ^{[18
]}

Weber, Donna M. ^{[19
]}

Yahalom, Joachim ^{[20
]}

Yunus, Furhan

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[2] Univ Michigan Comprehens Canc Ctr, Ann Arbor, MI USA

[3] Roswell Pk Canc Inst, Buffalo, NY USA

[4] Fox Chase Canc Ctr, Philadelphia, PA USA

[5] Ohio State Univ Comprehens Canc Ctr James Canc Ho, Columbus, OH USA

[6] Solove Res Inst, Columbus, MS USA

[7] Nebraska Med Ctr, UNMC Eppley Canc Ctr, Omaha, NE USA

[8] Duke Canc Inst, Durham, NC USA

[9] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Sidney, BC, Canada

[10] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[11] Stanford Canc Inst, Stanford, CA USA

[12] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA

[13] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA

[14] City Hope Comprehens Canc Ctr, Duarte, CA USA

[15] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[16] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[17] Washington Univ Sch Med, Washington, DC USA

[18] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[19] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[20] Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2011年 / 9卷 / 10期

关键词：

NCCN Clinical Practice Guidelines; NCCN Guidelines; multiple myeloma; Waldenstrom's monoclonal protein; C-reactive protein; combination chemotherapy; stem cell transplant; primary amyloidosis; cytogenetics; proteasome inhibitor; immunomodulatory drugs; bisphosphonates; supportive therapies; novel therapies; STEM-CELL TRANSPLANTATION; HIGH-DOSE THERAPY; THALIDOMIDE PLUS DEXAMETHASONE; DONOR LYMPHOCYTE INFUSIONS; PEGYLATED LIPOSOMAL DOXORUBICIN; NEWLY-DIAGNOSED MYELOMA; HIGH RESPONSE RATES; LONG-TERM SURVIVAL; PHASE-III; INTERGROUPE-FRANCOPHONE;

D O I：

10.6004/jnccn.2011.0095

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1146 / 1183

页数：38

共 50 条

[31] Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Raza, Shahzad
Safyan, Rachael A.
Lentzsch, Suzanne
CURRENT CANCER DRUG TARGETS, 2017, 17 (09) : 846 - 857
[32] Stem cell transplantation for multiple myeloma
Kumar, Shaji
CURRENT OPINION IN ONCOLOGY, 2009, 21 (02) : 162 - 170
[33] Bortezomib for previously untreated multiple myeloma
Delforge, Michel
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (16) : 2553 - 2564
[34] Multiple Myeloma
Holstein, Sarah A.
Liu, Hong
McCarthy, Philip L.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (06) : 1113 - +
[35] Bortezomib for previously untreated multiple myeloma
de la Rubia, Javier
Roig, Monica
EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (04) : 381 - 398
[36] Bortezomib in Multiple Myeloma: A Practice Guideline
Kouroukis, C. T.
Baldassarre, F. G.
Haynes, A. E.
Imrie, K.
Reece, D. E.
Cheung, M. C.
CLINICAL ONCOLOGY, 2014, 26 (02) : 110 - 119
[37] Multiple Myeloma
Rajkumar, S. Vincent
CURRENT PROBLEMS IN CANCER, 2009, 33 (01) : 7 - 64
[38] Knowing the unknowns in high risk multiple myeloma
Derman, Benjamin A.
Kosuri, Satyajit
Jakubowiak, Andrzej
BLOOD REVIEWS, 2022, 51
[39] Bortezomib for the treatment of previously untreated multiple myeloma
Romano, Alessandra
Conticello, Concetta
Di Raimondo, Francesco
IMMUNOTHERAPY, 2013, 5 (04) : 327 - 352
[40] New developments in the treatment of patients with multiple myeloma
Minnema, M. C.
van der Spek, E.
van de Donk, N. W. C. J.
Lokhorst, H. M.
NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (01) : 24 - 32

← 1 2 3 4 5 →